Unipolar Depression

Search with Google Search with Bing
Information
Disease name
Unipolar Depression
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03191058 Active, not recruiting N/A Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression June 26, 2018 November 7, 2024
NCT00125957 Completed Phase 3 The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression August 2005 December 2011
NCT00158990 Completed Phase 3 Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression. October 2002 July 2007
NCT00178074 Completed Phase 4 The Effects of Sleep Deprivation on Antidepressant Response February 1999 April 2003
NCT00178100 Completed Phase 4 Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-being in Elderly Individuals With Depression March 1999 August 2005
NCT00179244 Completed Phase 3 Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression July 2004 April 2005
NCT00186784 Completed Early Phase 1 Transcranial Magnetic Treatment (TMS) in Unipolar Depression December 2000 July 2011
NCT00226356 Completed Phase 4 Natural Supplements for Unipolar Depression December 2004 September 17, 2008
NCT00265291 Completed Phase 2 Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group November 1999 October 2008
NCT00319540 Completed Phase 2 RCT of Psychoeducational Program of Depression March 2001 March 2002
NCT03685942 Completed N/A Efficacy of Light Therapy Device LUMINETTE® in Major Depressive Disorder January 16, 2019 September 8, 2023
NCT01544205 Completed N/A Neurofeedback as a Treatment Tool for Depression March 2012 September 2014
NCT01562184 Completed Phase 2/Phase 3 Investigating tDCS as a Treatment for Unipolar and Bipolar Depression June 2012 October 2015
NCT01644747 Completed Phase 2 tDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients July 19, 2012 March 1, 2022
NCT01880957 Completed N/A PET and MRI Brain Imaging of Bipolar Disorder November 8, 2011 June 23, 2017
NCT01881763 Completed Phase 4 Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression June 2010 July 2017
NCT02104232 Completed N/A Thinking Healthy Program - Peer Delivered, India (THPP-I) October 2014 May 2017
NCT02111915 Completed N/A Thinking Healthy Program - Peer Delivered (Pakistan) October 2014 February 2017
NCT02401139 Completed Phase 1 Ketamine Trial for the Treatment of Depression March 2015 September 2015
NCT02407704 Completed Phase 4 A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise March 2015 December 2016
NCT02530164 Completed N/A Transcranial Direct Current Stimulation (tDCS) As Treatment for Major Depression September 2015 February 2021
NCT02750631 Completed N/A Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression April 2014 July 2017
NCT02771535 Completed N/A Long-term Efficacy of Metacognitive Training for Depression (D-MCT) March 2016 May 2017
NCT02822443 Completed Phase 2 Improve: Integrating Emotion Focused Components Into Psychological Therapy April 2015 August 2019
NCT03033420 Completed N/A Reducing the Rate and Duration of Re-ADMISsions Among Patients With Unipolar Disorder and Bipolar Disorder Using Smartphone-based Monitoring and Treatment - The RADMIS Trials May 15, 2017 May 1, 2021
NCT03113968 Completed Phase 2/Phase 3 ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) April 7, 2017 November 17, 2022
NCT03156504 Completed Phase 4 The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression. June 1, 2017 March 12, 2020
NCT03256162 Completed Phase 1 Ketamine as an Adjunctive Therapy for Major Depression September 7, 2017 September 21, 2018
NCT03268434 Completed N/A Evaluation of Metacognitive Training for Depression (D-MCT) in Outpatient Care October 10, 2017 September 24, 2019
NCT03315897 Completed Phase 2 Effects of Erythropoietin on Cognition and Neural Activity in Mood Disorders July 5, 2017 October 1, 2022
NCT03339596 Completed Phase 2 Effects of Erythropoietin for Cognitive Side-effects of ECT June 26, 2017 February 10, 2023
NCT00001545 Completed Phase 2 Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders May 1996 July 2006
NCT04420793 Completed Voice Changes During ECT November 7, 2019 February 17, 2021
NCT04701866 Completed N/A Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression January 11, 2021 August 24, 2022
NCT04781127 Completed Phase 1 Home-administered tDCS for Treatment of Depression February 10, 2021 August 10, 2022
NCT04889976 Completed N/A Portable Transcranial Electrical Stimulation and Internet-Based Behavioral Therapy for Major Depression Study May 22, 2021 October 21, 2022
NCT05388539 Completed N/A TBS Treatment for Treatment-Resistant Depression June 6, 2022 April 1, 2024
NCT00517387 Completed Phase 3 The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression September 2007 September 2010
NCT00714090 Completed Phase 3 Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression May 2008 July 2013
NCT00901407 Completed N/A Lamotrigine Augmentation in Resistant Depression December 2003 April 2007
NCT00914680 Completed Phase 3 Berlin Magnetic Seizure Therapy Depression Trial 01 June 2009 May 2013
NCT00922064 Completed Phase 4 Effects of Electroconvulsive Therapy (ECT) on Serotonin-1A Receptor Binding June 2009 September 2011
NCT00964054 Completed Phase 1 Depression Outcomes Study of Exercise September 2012 February 2013
NCT01049347 Completed Phase 3 Amitriptyline and Paroxetine Treatment of Major Depression October 1997 May 2000
NCT01132872 Completed PET Whole Body Distribution Studies Using [11C]CUMI April 30, 2010 April 12, 2012
NCT01360307 Completed Validation of the Spanish Version of the Clinically Useful Depression Outcome Scale (CUDOS) Scale June 2011 November 2011
NCT01447602 Completed Phase 3 A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior September 2011 June 2014
NCT06126198 Enrolling by invitation N/A rTMS Feasibility Study on Adolescent Depression Stimulation January 1, 2022 December 31, 2023
NCT06363981 Not yet recruiting N/A Multisite rTMS for Mood, Cognitive Impairment and Other Symptoms of Depression May 2024 April 2027
NCT06371352 Not yet recruiting N/A Effect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression May 2024 May 2027
NCT04059952 Recruiting Mechanism of Action of Electroconvulsive Therapy June 28, 2019 December 1, 2024
NCT04370002 Recruiting Sensor-based Characterization of Depression January 28, 2020 November 30, 2024
NCT03711019 Recruiting N/A Efficacy of Convulsive Therapies During Continuation October 22, 2018 September 2024
NCT03895658 Recruiting Phase 1 Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST) June 23, 2024 December 31, 2025
NCT05570110 Recruiting Phase 1/Phase 2 Enoxolone in Major Depression - Biomarker-outcome Relationship September 23, 2022 March 2025
NCT04939649 Recruiting Phase 3 Ketamine as an Adjunctive Therapy for Major Depression (2) September 13, 2021 December 1, 2024
NCT05801562 Recruiting Development of a Software Tool, Using Artificial Intelligence, That Integrates Clinical, Biological, Genetic and Imaging Data to Predict Diagnosis and Outcome of Depressed Patients in Order to Enhance Prognosis and Limiting Healthcare Costs. July 14, 2020 February 14, 2025
NCT05894980 Recruiting N/A How to Reduce Suicidal Thoughts and Impulsivity in Depression September 1, 2023 February 2026
NCT01557192 Suspended Phase 1 Low Field Magnetic Stimulation (LFMS) in Mood Disorders: 6 Treatments May 2010 May 2020
NCT00369915 Terminated Phase 2 The Antidepressant Efficacy of the Anticholinergic Scopolamine August 2006 January 2013
NCT00617162 Terminated N/A Deep Brain Stimulation for Major Depressive Disorder March 2008 June 2015
NCT02710279 Terminated N/A Response to Social Rejection in Suicidal Behavior February 19, 2016 February 15, 2018
NCT01219686 Terminated Phase 2/Phase 3 EScitalopram PIndolol ONset of Action October 2010 June 2013
NCT04712968 Terminated N/A Efficacy of Daylight as Adjunctive Treatment in Patients With Depression September 1, 2021 June 1, 2022
NCT00055575 Terminated Phase 2 Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies February 27, 2003 February 2, 2015
NCT01574742 Unknown status Phase 1 Open Study Assessing the Feasibility of Minocycline in Patients With Unipolar Depression June 2012 June 2014
NCT03227133 Unknown status N/A Oral Fluency and the Response to Antidepressant Therapy in the Elderly With a Unipolar Depressive Episode December 23, 2016 June 23, 2019
NCT01694030 Unknown status Phase 1 Effects of Repeated Attachment Security Priming on Depressed Mood: a Clinical Study November 2012 December 2014
NCT04717921 Unknown status Assesment of Retinal Nerve Fiber Layer in First Episode Depressive Patients Using Selective Serotonin Reuptake Inhibitor September 1, 2020 September 1, 2021
NCT03358056 Unknown status N/A Effects of Mindfulness Based Cognitive Therapy on Emotional Processing September 1, 2017 April 1, 2018
NCT01894932 Unknown status N/A MBCGT and Psycho-physiological Stress Regulation Group for Depression and Psycho-physiological Stress Patient April 2011 August 2016
NCT01012856 Unknown status Phase 2 Randomized Clinical Trial of an Exposure-based Cognitive Therapy for Depression January 2010 March 2014
NCT01313403 Withdrawn N/A Imaging Serotonin 5HT1A Receptors in Patients With Major Depressive Disorder February 10, 2011 April 25, 2012